
We’re excited to announce that our team has contributed to five posters being presented at this year’s prestigious European Haematological Association (EHA) annual conference. As haematology is one of our specialist areas, we are especially proud to contribute to this event. A special thanks to Dr Sara Ekberg for her efforts and contributions to these projects.
Also, Dr Joshua Entrop will be attending the conference in person. If you’re interested in discussing new project ideas or simply want to catch up over coffee, don’t hesitate to reach out to him.
List of posters at EHA25
- Increased Risk of Infections in Individuals with Smoldering Multiple Myeloma: Results from the Screened iStopMM Study (abstract no. PS1748)
- Barriers for Trial Inclusion and Impact on Survival for Mantle Cell Lymphoma Patients Within and Outside of the Randomized Phase II/II Trial ENRICH (abstract no. PS1880)
- Can Mantle Cell Lymphoma Be Cured? Insights from 25 Years of Follow-Up in the Nordic MCL2 and MCL3 Trials (abstract no. PF880)
- Real-World Treatment Patterns and Outcomes in High-Risk, Treatment-Naive Mantle Cell Lymphoma: A Multinational Analysis From the UK, Sweden, and France (abstract no. PF890)
- Real-World Treatment Patterns and Outcomes Among Patients With Treatment-Naive Mantle Cell Lymphoma in the UK, Sweden, and France (abstract no. PS1882)